|
J Biol Chem, Vol. 274, Issue 50, 35639-35646, December 10, 1999
Anatomy of a Homeoprotein Revealed by the Analysis of Human MODY3
Mutations*
Martine
Vaxillaire §¶,
Amar
Abderrahmani§,
Philippe
Boutin§,
Bernard
Bailleul§,
Philippe
Froguel§,
Moshe
Yaniv , and
Marco
Pontoglio
From the Unité des Virus Oncogènes,
Unité de Recherche Associée 1644, Centre National de la
Recherche Scientifique, Département des Biotechnologies, Institut
Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France and
§ Institut de Biologie de Lille, Unité Propre de
Recherche et d'Enseignement Supérieur A 8090, Centre National de
la Recherche Scientifique, Institut Pasteur de Lille, 1 rue du
Professeur Calmette, BP 245, 59019 Lille, France
Hepatocyte nuclear factor 1 (HNF1 ) is an
atypical dimeric homeodomain-containing protein that is expressed in
liver, intestine, stomach, kidney, and pancreas. Mutations in the
HNF1 gene are associated with an autosomal dominant form of
non-insulin-dependent diabetes mellitus called
maturity-onset diabetes of the young (MODY3). More than 80 different
mutations have been identified so far, many of which involve highly
conserved amino acid residues among vertebrate HNF1 . In the present
work, we investigated the molecular mechanisms by which MODY3 mutations
could affect HNF1 function. For this purpose, we analyzed the
properties of 10 mutants resulting in amino acid substitutions or
protein truncation. Some mutants have a reduced protein stability,
whereas others are either defective in the DNA binding or impaired in
their intrinsic trans-activation potential. Three mutants,
characterized by a complete loss of trans-activation, behave as
dominant negatives when transfected with the wild-type protein. These
data define a clear causative relationship between MODY3 mutations and
functional defects in HNF1 trans-activation. In addition, our
analysis sheds new light on the structure of a homeoprotein playing a
key role in pancreatic cell function.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Present address: Institut de Biologie de Lille, Unité
Propre de Recherche et d'Enseignement Supérieur A 8090, Centre
National de la Recherche Scientifique, Institut Pasteur de Lille, 1 rue du Professeur Calmette, BP 245, 59019 Lille, France.
To whom correspondence should be addressed: Unité des
Virus Oncogènes, Unité de Recherche Associée 1644, Centre National de la Recherche Scientifique, Département des
Biotechnologies, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex
15, France. Tel.: 33-1-45-68-85-12; Fax: 33-1-40-61-30-33; E-mail:
yaniv@pasteur.fr.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. W. Harries, M. J. Sloman, E. A.C. Sellers, A. T. Hattersley, and S. Ellard
Diabetes Susceptibility in the Canadian Oji-Cree Population Is Moderated by Abnormal mRNA Processing of HNF1A G319S Transcripts
Diabetes,
July 1, 2008;
57(7):
1978 - 1982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Vaxillaire and P. Froguel
Monogenic Diabetes in the Young, Pharmacogenetics and Relevance to Multifactorial Forms of Type 2 Diabetes
Endocr. Rev.,
May 1, 2008;
29(3):
254 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bellanne-Chantelot, C. Carette, J.-P. Riveline, R. Valero, J.-F. Gautier, E. Larger, Y. Reznik, P.-H. Ducluzeau, A. Sola, A. Hartemann-Heurtier, et al.
The Type and the Position of HNF1A Mutation Modulate Age at Diagnosis of Diabetes in Patients with Maturity-Onset Diabetes of the Young (MODY)-3
Diabetes,
February 1, 2008;
57(2):
503 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Tward, K. D. Jones, S. Yant, S. T. Cheung, S. T. Fan, X. Chen, M. A. Kay, R. Wang, and J. M. Bishop
Distinct pathways of genomic progression to benign and malignant tumors of the liver
PNAS,
September 11, 2007;
104(37):
14771 - 14776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Winckler, M. N. Weedon, R. R. Graham, S. A. McCarroll, S. Purcell, P. Almgren, T. Tuomi, D. Gaudet, K. B. Bostrom, M. Walker, et al.
Evaluation of Common Variants in the Six Known Maturity-Onset Diabetes of the Young (MODY) Genes for Association With Type 2 Diabetes
Diabetes,
March 1, 2007;
56(3):
685 - 693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. W. Harries, S. Ellard, A. Stride, The European MODY consortium, N. G. Morgan, and A. T. Hattersley
Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes
Hum. Mol. Genet.,
July 15, 2006;
15(14):
2216 - 2224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Rowley, L. J. Staloch, J. K. Divine, S. P. McCaul, and T. C. Simon
Mechanisms of mutual functional interactions between HNF-4{alpha} and HNF-1{alpha} revealed by mutations that cause maturity onset diabetes of the young
Am J Physiol Gastrointest Liver Physiol,
March 1, 2006;
290(3):
G466 - G475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Barbacci, A. Chalkiadaki, C. Masdeu, C. Haumaitre, L. Lokmane, C. Loirat, S. Cloarec, I. Talianidis, C. Bellanne-Chantelot, and S. Cereghini
HNF1{beta}/TCF2 mutations impair transactivation potential through altered co-regulator recruitment
Hum. Mol. Genet.,
December 15, 2004;
13(24):
3139 - 3149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bellanne-Chantelot, D. Chauveau, J.-F. Gautier, D. Dubois-Laforgue, S. Clauin, S. Beaufils, J.-M. Wilhelm, C. Boitard, L.-H. Noel, G. Velho, et al.
Clinical Spectrum Associated with Hepatocyte Nuclear Factor-1{beta} Mutations
Ann Intern Med,
April 6, 2004;
140(7):
510 - 517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. W. Harries, A. T. Hattersley, and S. Ellard
Messenger RNA Transcripts of the Hepatocyte Nuclear Factor-1{alpha} Gene Containing Premature Termination Codons Are Subject to Nonsense-Mediated Decay
Diabetes,
February 1, 2004;
53(2):
500 - 504.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. B. Smith, R. Gasa, H. Watada, J. Wang, S. C. Griffen, and M. S. German
Neurogenin3 and Hepatic Nuclear Factor 1 Cooperate in Activating Pancreatic Expression of Pax4
J. Biol. Chem.,
October 3, 2003;
278(40):
38254 - 38259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Divine, S. P. McCaul, and T. C. Simon
HNF-1{alpha} and endodermal transcription factors cooperatively activate Fabpl: MODY3 mutations abrogate cooperativity
Am J Physiol Gastrointest Liver Physiol,
June 9, 2003;
285(1):
G62 - G72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bjorkhaug, J. V. Sagen, P. Thorsby, O. Sovik, A. Molven, and P. R. Njolstad
Hepatocyte Nuclear Factor-1{alpha} Gene Mutations and Diabetes in Norway
J. Clin. Endocrinol. Metab.,
February 1, 2003;
88(2):
920 - 931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Stride, M. Shepherd, T. M. Frayling, M. P. Bulman, S. Ellard, and A. T. Hattersley
Intrauterine Hyperglycemia Is Associated With an Earlier Diagnosis of Diabetes in HNF-1{alpha} Gene Mutation Carriers
Diabetes Care,
December 1, 2002;
25(12):
2287 - 2291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Klupa, J. H. Warram, A. Antonellis, M. Pezzolesi, M. Nam, M. T. Malecki, A. Doria, S. S. Rich, and A. S. Krolewski
Determinants of the Development of Diabetes (Maturity-Onset Diabetes of the Young-3) in Carriers of HNF-1{alpha} Mutations: Evidence for parent-of-origin effect
Diabetes Care,
December 1, 2002;
25(12):
2292 - 2301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ferrer
A Genetic Switch in Pancreatic {beta}-Cells: Implications for Differentiation and Haploinsufficiency
Diabetes,
August 1, 2002;
51(8):
2355 - 2362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Triggs-Raine, R. D. Kirkpatrick, S. L. Kelly, L. D. Norquay, P. A. Cattini, K. Yamagata, A. J. G. Hanley, B. Zinman, S. B. Harris, P. H. Barrett, et al.
HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community
PNAS,
April 2, 2002;
99(7):
4614 - 4619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Eeckhoute, P. Formstecher, and B. Laine
Maturity-Onset Diabetes of the Young Type 1 (MODY1)-Associated Mutations R154X and E276Q in Hepatocyte Nuclear Factor 4{{alpha}} (HNF4{{alpha}}) Gene Impair Recruitment of p300, a Key Transcriptional Coactivator
Mol. Endocrinol.,
July 1, 2001;
15(7):
1200 - 1210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. PONTOGLIO
Hepatocyte Nuclear Factor 1, a Transcription Factor at the Crossroads of Glucose Homeostasis
J. Am. Soc. Nephrol.,
November 1, 2000;
11(90002):
S140 - S143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Triggs-Raine, R. D. Kirkpatrick, S. L. Kelly, L. D. Norquay, P. A. Cattini, K. Yamagata, A. J. G. Hanley, B. Zinman, S. B. Harris, P. H. Barrett, et al.
HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community
PNAS,
April 2, 2002;
99(7):
4614 - 4619.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|